Literature DB >> 6601157

False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents.

A Tarkowski, L M Bjursten, L A Nilsson, H Nygren.   

Abstract

A recently developed, simple immunological method, diffusion-in-gel ELISA, has been adapted for class-specific determination of rheumatoid factor (RF). Evidence was obtained of an analytical error due to interaction between RF and antigenic determinants on the Fc part of the indicator immunoglobulin (Ig) molecules used. This was eliminated by replacing the usual indicator reagent, complete Ig molecules, by conjugated Fab or F(ab')2 fragments. The findings imply that unless the RF-Fc interaction mentioned is avoided in the assaying technique, false positive results may be obtained for, e.g. IgG RF and IgA RF in sera containing IgM RF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601157     DOI: 10.1016/0022-1759(83)90273-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Autoantibodies and immunoglobulins in collagenous colitis.

Authors:  J Bohr; C Tysk; P Yang; D Danielsson; G Järnerot
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

2.  Secretory IgA and IgM antibodies to E. coli O and poliovirus type I antigens occur in amniotic fluid, meconium and saliva from newborns. A neonatal immune response without antigenic exposure: a result of anti-idiotypic induction?

Authors:  L Mellander; B Carlsson; L A Hanson
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

3.  Intra-articular immunization induces strong systemic immune response in humans.

Authors:  C Trollmo; H Carlsten; A Tarkowski
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Local production of IgA- and IgM-rheumatoid factors in adult periodontal disease.

Authors:  H Z Hirsch; A Tarkowski; W J Koopman; J Mestecky
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

5.  Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumab.

Authors:  S Mojtahed Poor; T Ulshöfer; L A Gabriel; M Henke; M Köhm; F Behrens; G Geisslinger; M J Parnham; H Burkhardt; S Schiffmann
Journal:  Clin Exp Immunol       Date:  2019-02-03       Impact factor: 4.330

6.  Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study.

Authors:  A Tarkowski; C Czerkinsky; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

7.  Rheumatoid factors in psoriatic arthropathy and in Waaler-Rose negative rheumatoid arthritis.

Authors:  A Tarkowski; L A Nilsson
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

8.  Enzyme-linked immunosorbent assay (ELISA) screening test for detection of rheumatoid factor.

Authors:  T Jonsson; J A Arnason; H Valdimarsson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man.

Authors:  A Tarkowski; C Czerkinsky; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

10.  Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis.

Authors:  L Kanerud; G N Engström; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.